Cargando…
Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer
Up-regulation of serum ephrinA2 is common in various malignancies and has been suggested as a potential biomarker for the diagnosis and prognosis of prostate cancer (PCa). However, the type of serum ephrinA2 expressed in PCa patients remains elusive. Furthermore, the level of exosomal ephrinA2 deriv...
Autores principales: | Li, Shibao, Zhao, Yao, Chen, Wenbai, Yin, Lingyu, Zhu, Jie, Zhang, Haoliang, Cai, Chenchen, Li, Pengpeng, Huang, Lingyan, Ma, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072821/ https://www.ncbi.nlm.nih.gov/pubmed/30087706 http://dx.doi.org/10.7150/jca.25201 |
Ejemplares similares
-
Role of EphrinA3 in HIV-1 Neuropathogenesis
por: Singal, Chitra Mohinder Singh, et al.
Publicado: (2021) -
ADAM10-cleaved ephrin-A5 contributes to prostate cancer metastasis
por: Cai, Chenchen, et al.
Publicado: (2022) -
EphrinA5 protein distribution in the developing mouse brain
por: Deschamps, Claire, et al.
Publicado: (2010) -
Design and evaluation of EphrinA1 mutants with cerebral protective effect
por: Zhu, Yuanjun, et al.
Publicado: (2017) -
EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice
por: DuSablon, Augustin, et al.
Publicado: (2017)